A comprehensive view of Pierre Fabre S.A.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Beauty & Personal Care Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

INTERNATIONAL PATENT: PIERRE FABRE MEDICAMENT FILES APPLICATION FOR "USE OF A LIQUID AQUEOUS COMPOSITION FOR SOLUBILIZATION AND STABILIZATION OF AN ANTIBODY-DRUG CONJUGATE"
Published: April 20, 2024 by U.S. Fed News
Australia: Pierre Fabre Medicament Receives Patent for 'Use of Copaifera oleoresin in pathologies of the prostate'
Published: April 12, 2024 by Australian Government
Australia: Pierre Fabre Dermo-Cosmetique Receives Patent for 'Combination of a retinoid and an extract of Silybum marianum (L.) Gaertn'
Published: April 05, 2024 by Australian Government
Clinical Skin acquires Pierre Fabre Labs' brand Glytone, known for being a market pioneer in active acids use, particularly its use of Free Glycolic Acid and its targeted skin care solutions
Published: March 26, 2024 by CosmeticsDesign.com (US)
Patent Issued for Antibody-drug-conjugate and its use for the treatment of cancer (USPTO 11918656)
Published: March 26, 2024 by NewsRx Pharma Business Daily

Ask us about our Beauty & Personal Care market view

Trending Chart

Interactive chart with headline count